INFORMED.
LIVE

ASTAL LABORATORIES LIMITED

BSE: ASTALLTD512600ISIN INE307N01014
  • Healthcare
  • Pharmaceuticals

Share price

₹70.00-3.00 (-4.11%)
as of 18 Sep 2026
ASTAL LABORATORIES LIMITED share price, 18 Sep 2025 to 18 Sep 2026: ₹82.52 to ₹70.00 (-15.2%). Low ₹61.88, high ₹100.56. Volume shown below the price.
52W high
₹103.20
52W low
₹60.45
Off 52W high
-32.17%
1M return
-12.76%
3M return
-14.40%
6M return
-5.14%
1Y return
-15.17%
20D avg volume
15,494
50 DMA
₹80.49
200 DMA
₹78.54

Key ratios Consolidated

Market cap
₹306.59 Cr
Current price
₹70.00
52W high / low
₹103.20 / ₹60.45
Face value
₹10.00
P/E
0.00
P/B
EPS (TTM)
₹0.00
Book value / share
ROE
ROCE
5.60%
Operating margin
Net margin
Debt / equity
0.15
Net debt
₹47.78 Cr
Interest cover
9.73
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
146.6 days

Financials

MetricQ1 FY27Q4 FY26Q4 FY25
Income statement
100.94134.05
0.140.10
90.72125.81
100.12108.25
0.000.00
3.153.72
1.181.09
0.860.86
2.822.53
10.358.34
0.000.00
10.358.34
0.930.66
9.427.68
2.192.04
Key metrics
12.3910.29
12.30%7.70%
9.30%5.70%
2.70%
MetricFY26FY25
Income statement
249.13
0.22
231.62
224.91
0.00
5.02
2.03
1.23
4.32
17.73
0.00
17.73
3.02
14.71
8.62
Key metrics
20.99
8.40%
5.90%
5.60%
-19.09
-1.20
0.15
47.78
146.6
Balance sheet
518.19
243.50
1.30
156.35
67.52
18.04
63.71
123.80
164.29
49.08
30.44
18.64
333.76
Cash flow
-17.70
-2.17
2.58
1.39
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
39.5140.9252.2437.5225.3323.47
0.030.070.040.030.060.04
34.5939.5149.1434.0822.5919.65
40.8236.2354.4939.0823.0824.84
0.000.000.000.000.000.00
0.620.810.440.420.450.09
0.330.470.330.310.300.27
0.180.320.120.120.120.10
0.650.461.120.410.260.84
4.961.473.133.472.793.85
0.000.000.000.000.000.00
4.961.473.133.472.793.85
1.250.390.770.890.701.10
3.711.092.362.582.092.74
0.860.292.192.402.122.80
Key metrics
5.472.263.583.903.214.22
13.80%5.50%6.90%10.40%12.70%18.00%
9.40%2.70%4.50%6.90%8.30%11.70%
0.60%8.50%11.30%
56.00%74.40%
77.50%-60.20%
MetricTTMFY26FY25FY24
Income statement
170.19156.0064.23
0.170.190.13
157.32145.3252.38
170.62152.8861.81
0.000.000.00
2.292.111.34
1.441.410.70
0.740.690.22
2.642.242.00
13.0310.8711.98
0.000.000.00
13.0310.8711.98
3.302.753.05
9.748.128.93
5.744.769.08
Key metrics
15.2112.9712.90
8.94%8.30%20.10%
5.72%5.20%13.90%
3.70%34.70%
142.90%
-9.10%
-3.49-12.52
-0.38-1.40
0.040.37
11.2611.54
110.0179.9
Balance sheet
399.5763.34
103.2645.64
0.701.73
72.3027.66
28.7814.76
1.491.49
11.3611.44
54.0710.77
71.1126.77
11.9613.27
11.5912.81
0.370.46
327.1635.99
Cash flow
-3.08-12.52
-1.28-7.81
4.553.29
0.410.00

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
4.53%
HolderTypeHoldingPreviousChange
Sesha Sai Nikhil ChintalapatiPublic11.38%
Suryanarayana Raju Rudraraju .Public6.75%
Kommera HarishPublic6.43%
Amit MishraPublic4.57%
Aceso Research Labs LlpPromoter4.53%
Abraham GeorgePublic4.40%
Liju MathewPublic3.81%
Pavani VupparapalliPublic3.77%
Venkataramana Reddy MallelaPublic2.85%
Pradeepkumar M GPublic2.65%
Doradla Radha KrishnaPublic2.57%
K S Srinivas RaoPublic1.90%
Kunapareddy Bala Gopala Krishna Rao .Public1.28%
Nitin GuptaPublic1.14%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results